What
- Target validation and research in
- Oncology,
- Cardiology (including kidney and lung diseases),
- Gynecological therapies,
- Hematology.
Where
Global
Who
- Universities
- Other academic research institutes
- Startup and biotech companies from all over the world with an interest in pharmaceutical R&D
What do we offer
- Research grants for drug targets from €5,000 to €125,000, whereby intellectual property rights remain with the applicant.
- Our expertise and technologies to help testing the respective hypothesis.
- A Bayer contact to help you with any questions; this may lead to opportunities for further collaboration with Bayer.
The Grants4Targets crowdsourcing initiative in health offers you financial support to validate your pharmaceutical target and help test your hypothesis.
